Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin application. It is used to treat dermatophyte infections of the skin, hair and nails in both adults and children when prescribed by a qualified healthcare professional.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company adheres to WHO GMP guidelines and provides comprehensive documentation for import and distribution.

Lamisil (terbinafine) is used to treat superficial fungal infections caused by dermatophytes.

- Tinea pedis: relieves itching and clears fungal infection of the feet. - Tinea corporis: eliminates ring‑shaped skin lesions caused by dermatophytes. - Tinea cruris: resolves fungal infection of the groin and inner thigh area. - Onychomycosis: improves appearance and reduces fungal load in infected toenails.

Terbinafine topical therapy may cause local skin reactions.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Redness: localized erythema. - Burning sensation: transient warmth or stinging. - Scaling: flaking of the treated skin. - Dryness: reduced moisture at the site. - Irritation: mild discomfort or prickling.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives. - Severe skin rash: extensive redness or blistering. - Facial or throat swelling: signs of angioedema. - Difficulty breathing: possible anaphylactic response. - Liver toxicity: rare systemic involvement. - Contact dermatitis: persistent inflammation.

Before using Lamisil, consider the following safety measures.

- Apply to clean, dry skin: follow label instructions for proper preparation. - Avoid use on broken skin: risk of increased irritation. - Do not cover treated area with occlusive dressings: may enhance absorption. - Discontinue if severe irritation occurs: seek medical advice promptly. - Store at room temperature: keep in the original container, protect from moisture and light.

Terbinafine may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Concurrent systemic antifungals (e.g., itraconazole): increased hepatotoxicity risk. - CYP2D6 inhibitors (e.g., fluoxetine): may raise terbinafine plasma levels. - Warfarin: monitor INR closely due to potential anticoagulant effect.

Moderate Interactions (Monitor Closely): - Alcohol consumption: may add strain to liver function. - Use with other topical agents (e.g., corticosteroids): could alter drug absorption. - Co‑application with skin irritants: increased risk of local irritation.